High-dose corticosteroids with or without etanercept for the treatment of idiopathic pneumonia syndrome after allo-SCT.
about
Concurrent treatment with a tumor necrosis factor-alpha inhibitor and veno-venous extracorporeal membrane oxygenation in a post-hematopoietic stem cell transplant patient with idiopathic pneumonia syndrome: a case reportLung parenchyma-derived IL-6 promotes IL-17A-dependent acute lung injury after allogeneic stem cell transplantationRandomized, double-blind, placebo-controlled trial of soluble tumor necrosis factor receptor: enbrel (etanercept) for the treatment of idiopathic pneumonia syndrome after allogeneic stem cell transplantation: blood and marrow transplant clinical triTNF-receptor inhibitor therapy for the treatment of children with idiopathic pneumonia syndrome. A joint Pediatric Blood and Marrow Transplant Consortium and Children's Oncology Group Study (ASCT0521).Blood and marrow transplant clinical trials network state of the Science Symposium 2014Idiopathic pneumonia syndrome after hematopoietic cell transplantation: evidence of occult infectious etiologiesA Critical Care and Transplantation-Based Approach to Acute Respiratory Failure after Hematopoietic Stem Cell Transplantation in Children.Proteome Profiling in Lung Injury after Hematopoietic Stem Cell Transplantation.Targeting the Canonical Nuclear Factor-κB Pathway with a High-Potency IKK2 Inhibitor Improves Outcomes in a Mouse Model of Idiopathic Pneumonia Syndrome.A call to arms: a critical need for interventions to limit pulmonary toxicity in the stem cell transplantation patient population.Risk factor analysis of idiopathic pneumonia syndrome after allogeneic hematopoietic SCT in children.Respiratory failure in the hematopoietic stem cell transplant recipient
P2860
Q33420620-964A2265-3F9D-4841-A7F3-E9973934EEECQ33758318-79939105-C58E-411B-A060-3F5F70EB42E7Q34027424-48CCD51D-0541-4CE0-BE6B-7832BBCA7EEDQ34858453-413156E5-B865-4E03-82BF-4C451BC153C4Q35591760-91922A9C-A6F2-4CC1-8B7E-B1C76B27A52EQ35724040-130E9768-D18D-4828-84B5-15D5FE191DD0Q37276584-192C729C-A839-45B0-951C-24D22696F7C4Q38447685-962E7DD7-E765-4267-96E3-AEC839056057Q38978799-0FC3CC4E-0037-4CF6-9624-50D1F283AF33Q39041930-CD102D63-30CB-4F55-B095-071F1778258DQ45799176-E9C26C69-82ED-444F-938D-E3AFE66B02ADQ58121933-3873FB58-34E9-4504-8939-F3156FFD9780
P2860
High-dose corticosteroids with or without etanercept for the treatment of idiopathic pneumonia syndrome after allo-SCT.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
High-dose corticosteroids with ...... monia syndrome after allo-SCT.
@en
High-dose corticosteroids with ...... monia syndrome after allo-SCT.
@nl
type
label
High-dose corticosteroids with ...... monia syndrome after allo-SCT.
@en
High-dose corticosteroids with ...... monia syndrome after allo-SCT.
@nl
prefLabel
High-dose corticosteroids with ...... monia syndrome after allo-SCT.
@en
High-dose corticosteroids with ...... monia syndrome after allo-SCT.
@nl
P2093
P2860
P356
P1476
High-dose corticosteroids with ...... monia syndrome after allo-SCT.
@en
P2093
D F Heitjan
D L Porter
E A Stadtmauer
E O Hexner
P2860
P2888
P304
P356
10.1038/BMT.2011.260
P407
P577
2012-02-06T00:00:00Z
P5875
P6179
1025483575